This overall network of interactions underscores the biological significance of pathways like MAPK/ERK and JAK-STAT, with proteins such as MAPK3, RAF1, and JAK2 serving as potential therapeutic targets for diseases in which these signaling pathways are dysregulated, such as cancer and inflammatory diseases. Here, RAF1 is linked to cancer.